EligibleTrials

Retinal Blood Flow and Autoregulation

Recruiting · NCT05344274 · Interventional (participants receive a specific treatment)

View the official record on ClinicalTrials.gov →
Hypertension

Interventions studied

Indocyanine Green AngiographyIsocapnic OxygenOcular Imaging with Optical Coherence Tomography (OCT) and Adaptive Optics (AO)

What this trial is about

The purpose of this study is to establish autoregulation of retinal blood flow in arterioles and capillaries as a biomarker for early primary open angle glaucoma.

Who can take part

Age range
18 Years to 88 Years
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Phase 4
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

4 locations listed across 1 US state.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.